Tsumura & Co. (TSE: 4540)
Health Care · Pharmaceuticals · JP
¥3,772.00
+1.86% today · +7.2% 1Y
Tsumura & Co. (TSE: 4540) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.78B and employs 4,923 people.
Over the last twelve months the share price has gained 7.2%, trading between 3.44K and 4.40K.
Tweenvest scores Tsumura & Co. across four factors: quality 79/100, value 63/100, growth 22/100, dividend 91/100. Its strongest factor is dividend.
4540 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.78B
- Revenue (TTM)
- $1.23B
- P/E
- 9.31
- EPS
- 405.00
- Dividend yield
- 4.19%
- Beta (5Y)
- 0.04
- 52-week high
- ¥4,403.00
- 52-week low
- ¥3,444.00
- Avg volume (3M)
- —
- Shares outstanding
- 74.55M
- Employees
- 4,923
- Next earnings
- —
About Tsumura & Co.
Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.
- ISIN
- JP3535800001
- Founded
- 1893
- Listed since
- Jan 1, 2001
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pfizer LimitedNSEI: PFIZER | $1.80B | Rs3,808.20 | +1.55% |
| Septerna, Inc.NasdaqGM: SEPN | $1.79B | $38.37 | +1.75% |
| Neuren Pharmaceuticals LimitedASX: NEU | $1.79B | AU$20.20 | -0.39% |
| Zhejiang Medicine Co., Ltd.SHSE: 600216 | $1.78B | CN¥12.59 | +1.29% |
| PharmaBlock Sciences (Nanjing), Inc.SZSE: 300725 | $1.77B | CN¥51.01 | -7.84% |
| Nuvation Bio Inc.NYSE: NUVB | $1.76B | $5.00 | -2.72% |
| Cohance Lifesciences LimitedNSEI: COHANCE | $1.74B | Rs441.00 | -2.28% |
| Shanghai Shyndec Pharmaceutical Co., Ltd.SHSE: 600420 | $1.70B | CN¥8.51 | +1.43% |
Figures last refreshed Oct 11, 2026.